Furthermore, immunochemical staining of RIPK1, RIPK3, and MLKL showed that YQJOF reduces hepatocytic RIPK1, RIPK3, and MLKL levels, which were upregulated in chronic liver injury, acute liver injury, and ACLF model (Figure 10F). Here, MLKL is linked to injury.